Search research articles
Contact Us
Filters
Showing results (71-80 of 77) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 77 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2014
First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors
Debashis Sarker, Joo Ern Ang, Richard Baird, et al.
Science Translational Medicine
|
June 3, 2011
A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma
Natsuko Suwaki, Elsa Vanhecke, Katelyn M Atkins, et al.
Cancer Research
|
April 3, 2009
Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer
Gerhardt Attard, Joost F Swennenhuis, David Olmos, et al.
Nature Reviews. Cancer
|
September 24, 2011
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan, Jermaine I Coward, Robert C Bast, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2013
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study
Joo Ern Ang, Charlie Gourley, C Bethan Powell, et al.
EMBO Molecular Medicine
|
March 12, 2021
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
Michal M Hoppe, Patrick Jaynes, Joanna D Wardyn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 16, 2019
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours
Robin L Jones, Mark J Ratain, Peter J O'Dwyer, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 77) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 77 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2014
First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors
Debashis Sarker, Joo Ern Ang, Richard Baird, et al.
Science Translational Medicine
|
June 3, 2011
A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma
Natsuko Suwaki, Elsa Vanhecke, Katelyn M Atkins, et al.
Cancer Research
|
April 3, 2009
Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer
Gerhardt Attard, Joost F Swennenhuis, David Olmos, et al.
Nature Reviews. Cancer
|
September 24, 2011
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan, Jermaine I Coward, Robert C Bast, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2013
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study
Joo Ern Ang, Charlie Gourley, C Bethan Powell, et al.
EMBO Molecular Medicine
|
March 12, 2021
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
Michal M Hoppe, Patrick Jaynes, Joanna D Wardyn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 16, 2019
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours
Robin L Jones, Mark J Ratain, Peter J O'Dwyer, et al.
Page
of 8